247 related articles for article (PubMed ID: 28730282)
1. Blockade of α2-adrenergic receptors in prelimbic cortex: impact on cocaine self-administration in adult spontaneously hypertensive rats following adolescent atomoxetine treatment.
Baskin BM; Nic Dhonnchadha BÁ; Dwoskin LP; Kantak KM
Psychopharmacology (Berl); 2017 Oct; 234(19):2897-2909. PubMed ID: 28730282
[TBL] [Abstract][Full Text] [Related]
2. Cocaine-seeking behavior in a genetic model of attention-deficit/hyperactivity disorder following adolescent methylphenidate or atomoxetine treatments.
Jordan CJ; Harvey RC; Baskin BB; Dwoskin LP; Kantak KM
Drug Alcohol Depend; 2014 Jul; 140():25-32. PubMed ID: 24811203
[TBL] [Abstract][Full Text] [Related]
3. Adolescent atomoxetine treatment in a rodent model of ADHD: effects on cocaine self-administration and dopamine transporters in frontostriatal regions.
Somkuwar SS; Jordan CJ; Kantak KM; Dwoskin LP
Neuropsychopharmacology; 2013 Dec; 38(13):2588-97. PubMed ID: 23822950
[TBL] [Abstract][Full Text] [Related]
4. Adolescent d-amphetamine treatment in a rodent model of attention deficit/hyperactivity disorder: impact on cocaine abuse vulnerability in adulthood.
Jordan CJ; Lemay C; Dwoskin LP; Kantak KM
Psychopharmacology (Berl); 2016 Dec; 233(23-24):3891-3903. PubMed ID: 27600990
[TBL] [Abstract][Full Text] [Related]
5. Methylphenidate treatment beyond adolescence maintains increased cocaine self-administration in the spontaneously hypertensive rat model of attention deficit/hyperactivity disorder.
Baskin BM; Dwoskin LP; Kantak KM
Pharmacol Biochem Behav; 2015 Apr; 131():51-6. PubMed ID: 25643872
[TBL] [Abstract][Full Text] [Related]
6. Performance on a strategy set shifting task during adolescence in a genetic model of attention deficit/hyperactivity disorder: methylphenidate vs. atomoxetine treatments.
Harvey RC; Jordan CJ; Tassin DH; Moody KR; Dwoskin LP; Kantak KM
Behav Brain Res; 2013 May; 244():38-47. PubMed ID: 23376704
[TBL] [Abstract][Full Text] [Related]
7. Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.
Somkuwar SS; Kantak KM; Dwoskin LP
J Neurosci Methods; 2015 Aug; 252():55-63. PubMed ID: 25680322
[TBL] [Abstract][Full Text] [Related]
8. Methylphenidate treatment in adolescent rats with an attention deficit/hyperactivity disorder phenotype: cocaine addiction vulnerability and dopamine transporter function.
Harvey RC; Sen S; Deaciuc A; Dwoskin LP; Kantak KM
Neuropsychopharmacology; 2011 Mar; 36(4):837-47. PubMed ID: 21150910
[TBL] [Abstract][Full Text] [Related]
9. Adolescent D-amphetamine treatment in a rodent model of ADHD: Pro-cognitive effects in adolescence without an impact on cocaine cue reactivity in adulthood.
Jordan CJ; Taylor DM; Dwoskin LP; Kantak KM
Behav Brain Res; 2016 Jan; 297():165-79. PubMed ID: 26467602
[TBL] [Abstract][Full Text] [Related]
10. Adolescence methylphenidate treatment in a rodent model of attention deficit/hyperactivity disorder: dopamine transporter function and cellular distribution in adulthood.
Somkuwar SS; Darna M; Kantak KM; Dwoskin LP
Biochem Pharmacol; 2013 Jul; 86(2):309-16. PubMed ID: 23623751
[TBL] [Abstract][Full Text] [Related]
11. Effects of dopamine D1 receptor blockade in the prelimbic prefrontal cortex or lateral dorsal striatum on frontostriatal function in Wistar and Spontaneously Hypertensive Rats.
Gauthier JM; Tassin DH; Dwoskin LP; Kantak KM
Behav Brain Res; 2014 Jul; 268():229-38. PubMed ID: 24755309
[TBL] [Abstract][Full Text] [Related]
12. Increased noradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.
Russell V; Allie S; Wiggins T
Behav Brain Res; 2000 Dec; 117(1-2):69-74. PubMed ID: 11099759
[TBL] [Abstract][Full Text] [Related]
13. Methylphenidate and venlafaxine attenuate locomotion in spontaneously hypertensive rats, an animal model of attention-deficit/hyperactivity disorder, through α2-adrenoceptor activation.
Umehara M; Ago Y; Kawanai T; Fujita K; Hiramatsu N; Takuma K; Matsuda T
Behav Pharmacol; 2013 Aug; 24(4):328-31. PubMed ID: 23751518
[TBL] [Abstract][Full Text] [Related]
14. Atomoxetine increases histamine release and improves learning deficits in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat.
Liu LL; Yang J; Lei GF; Wang GJ; Wang YW; Sun RP
Basic Clin Pharmacol Toxicol; 2008 Jun; 102(6):527-32. PubMed ID: 18346050
[TBL] [Abstract][Full Text] [Related]
15. Long Withdrawal of Methylphenidate Induces a Differential Response of the Dopaminergic System and Increases Sensitivity to Cocaine in the Prefrontal Cortex of Spontaneously Hypertensive Rats.
dos Santos Pereira M; Sathler MF; Valli Tda R; Marques RS; Ventura AL; Peccinalli NR; Fraga MC; Manhães AC; Kubrusly R
PLoS One; 2015; 10(10):e0141249. PubMed ID: 26509840
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of postsynapse adrenergic α2A receptor improves attention/cognition performance in an animal model of attention deficit hyperactivity disorder.
Kawaura K; Karasawa J; Chaki S; Hikichi H
Behav Brain Res; 2014 Aug; 270():349-56. PubMed ID: 24882610
[TBL] [Abstract][Full Text] [Related]
17. Atomoxetine-induced increases in monoamine release in the prefrontal cortex are similar in spontaneously hypertensive rats and Wistar-Kyoto rats.
Ago Y; Umehara M; Higashino K; Hasebe S; Fujita K; Takuma K; Matsuda T
Neurochem Res; 2014 May; 39(5):825-32. PubMed ID: 24634253
[TBL] [Abstract][Full Text] [Related]
18. Increased prefrontal hemodynamic change after atomoxetine administration in pediatric attention-deficit/hyperactivity disorder as measured by near-infrared spectroscopy.
Ota T; Iida J; Nakanishi Y; Sawada S; Matsuura H; Yamamuro K; Ueda S; Uratani M; Kishimoto N; Negoro H; Kishimoto T
Psychiatry Clin Neurosci; 2015 Mar; 69(3):161-70. PubMed ID: 25359429
[TBL] [Abstract][Full Text] [Related]
19. Effect of atomoxetine on hyperactivity in an animal model of attention-deficit/hyperactivity disorder (ADHD).
Moon SJ; Kim CJ; Lee YJ; Hong M; Han J; Bahn GH
PLoS One; 2014; 9(10):e108918. PubMed ID: 25271814
[TBL] [Abstract][Full Text] [Related]
20. Subchronic administration of atomoxetine causes an enduring reduction in context-induced relapse to cocaine seeking without affecting impulsive decision making.
Broos N; Loonstra R; van Mourik Y; Schetters D; Schoffelmeer AN; Pattij T; De Vries TJ
Addict Biol; 2015 Jul; 20(4):714-23. PubMed ID: 25056833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
